Loading clinical trials...
Loading clinical trials...
A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of Ampion in Adults With Pain Due to Osteoarthritis (OA) of the Knee
Conditions
Interventions
4 mL injection of Ampion
4 mL Injection of Placebo
Start Date
January 1, 2014
Primary Completion Date
May 1, 2014
Completion Date
July 1, 2014
Last Updated
August 9, 2022
NCT06927934
NCT01820650
NCT04145011
NCT01899508
NCT03349645
NCT04882319
Lead Sponsor
Ampio Pharmaceuticals. Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions